#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18248	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2014	888.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	1005	C	982	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18248	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2014	888.2	0	HET	.	.	.	C207T	.	207	207	C	441	441	C	1007	C,T	763,218	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	34040	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3556	944.9	0	.	n	.	0	T695C	SNP	695	695	T	1069	1069	C	1027	C	1005	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	34040	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3556	944.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	2012	2012	G	1074	G,A,T	529,510,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	34040	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3556	944.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2345	2345	C	1066	C,T	1035,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	34040	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3556	944.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2419	2419	A	1107	A	1071	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	34040	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3556	944.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2971	2971	C	1030	C	1002	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	14	blaTEM	861	209	99.04	blaTEM.l15.c4.ctg.1	209	2.6	0	.	p	.	0	I125fs	FSHIFT	373	373	A	4	4	A	1	A	1	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2318	folP	855	855	100.0	folP.l15.c4.ctg.1	1718	133.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1165	1167	AGC	234;236;236	A;G;C	231;234;233	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5890	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3254	178.4	1	SNP	p	S91F	1	.	.	271	273	TTC	500	502	TTC	191;189;189	T;T,C;C	185;183,1;185	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5890	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3254	178.4	1	SNP	p	G95N	0	.	.	283	285	GGC	512	514	GGC	190;183;183	G;G,A;C,A	185;177,1;179,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5890	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3254	178.4	1	SNP	p	D95G	1	.	.	283	285	GGC	512	514	GGC	190;183;183	G;G,A;C,A	185;177,1;179,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	2222	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1247	175.1	1	SNP	p	G45D	0	.	.	133	135	GGC	442	444	GGC	268;266;266	G;G,A;C	261;257,2;257	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1088	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1081	99.8	0	.	n	.	0	A197.	DEL	197	197	A	619	619	A	223	A	221	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5624	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2900	191.0	1	SNP	p	D86N	0	.	.	256	258	GAC	518	520	GAC	220;218;219	G;A;C	217;209;216	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5624	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2900	191.0	1	SNP	p	R87I	0	.	.	259	261	CGT	521	523	CGT	217;218;219	C,A;G,C;T	213,2;210,1;206	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5624	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2900	191.0	1	SNP	p	S87R	1	.	.	259	261	CGT	521	523	CGT	217;218;219	C,A;G,C;T	213,2;210,1;206	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5624	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2900	191.0	1	SNP	p	R87W	0	.	.	259	261	CGT	521	523	CGT	217;218;219	C,A;G,C;T	213,2;210,1;206	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5624	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2900	191.0	1	SNP	p	S88P	0	.	.	262	264	TCC	524	526	TCC	220;227;227	T;C;C	210;218;220	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5066	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2687	186.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1504	1506	GGC	239;235;237	G;G;C,T	233;228;222,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	5030	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2304	214.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1216	1218	GCC	285;290;292	G;C;C	276;281;280	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5030	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2304	214.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1219	1221	ATG	291;285;285	A;T;G	283;274;277	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5030	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2304	214.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1231	1233	ACC	272;270;268	A,T;C;C	260,1;265;263	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5030	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2304	214.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1231	1233	ACC	272;270;268	A,T;C;C	260,1;265;263	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5030	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2304	214.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1732	1734	ACC	228;230;230	A,C;C;C,T	209,1;221;222,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5030	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2304	214.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1786	1788	GCG	248;251;257	G;C;G	243;245;251	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5030	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2304	214.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1786	1788	GCG	248;251;257	G;C;G	243;245;251	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5030	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2304	214.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1909	1911	GGT	218;218;220	G;G,A;T	208;206,1;209	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5030	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2304	214.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1918	1920	AGC	203;200;196	A,G;G;C	185,1;191;181	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5030	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2304	214.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1936	1938	CCG	171;173;173	C,CGG;C,G;G,C	144,1;156,2;152,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6932	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3109	220.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1687	1689	CCG	235;239;238	C;C;G	222;234;226	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2778	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1637	166.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	485	485	C	184	C	174	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3446	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1575	215.4	0	.	p	.	0	I45V	NONSYN	133	135	ATT	468	470	GTT	280;280;280	G,A;T,G;T	270,4;266,1;270	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3446	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1575	215.4	1	SNP	p	G120K	1	.	.	358	360	AAG	693	695	AAG	252;252;254	A,G;A,G;G,T,A	236,3;243,3;234,3,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3446	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1575	215.4	1	SNP	p	A121N	1	.	.	361	363	AAC	696	698	AAC	255;257;255	A,G;A,C;C,A	247,3;249,3;241,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3446	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1575	215.4	1	SNP	p	N121D	0	.	.	361	363	AAC	696	698	AAC	255;257;255	A,G;A,C;C,A	247,3;249,3;241,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12484	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4869	253.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1422	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1231	114.5	1	SNP	p	V57M	1	.	.	169	171	ATG	643	645	ATG	279;282;282	A;T;G	273;274;274	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
